Author
J. O. Deasy
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
Biology Disciplines
Click to filter author papersSignature Assays, Organisms & Methods
Click to filter · or open tagActivity by Year
2019-2023 · peak 3/yrCo-Author Collaboration Network
10 top collaborators · 23 mutual co-author links6 papers
Recent·Most cited
- Cancer BiologybioRxivPreprint
Functional transcriptional signatures for tumor-type-agnostic phenotype prediction
C. Weistuch, K. A. Murgas, J. Zhu…·J. O. Deasy
The paper identifies six transcriptomic archetypes from normal tissues that correlate with cancer patient survival and drug sensitivity, suggesting cancer adopts normal tissue transcriptional features.
DOI 10.1101/2023.04.12.536595 - Cancer BiologybioRxiv
Gene interaction network analysis in multiple myeloma detects complex immune dysregulation associated with shorter survival
A. K. Simhal, K. H. Maclachlan, R. H. Elkin…·A. R. Tannenbaum
This study uses gene interaction network analysis in multiple myeloma to identify immune-related genes associated with shorter survival.
DOI 10.1038/s41408-023-00935-2 - Cancer BiologybioRxiv
Geometric Network Analysis Provides Prognostic Information in Patients with High Grade Serous Carcinoma of the Ovary Treated with Immune Checkpoint Inhibitors
R. Elkin, J. H. Oh, Y. L. Liu…·A. R. Tannenbaum
This paper introduces a network curvature-based method to predict prognosis in high-grade serous ovarian cancer patients treated with immune checkpoint inhibitors using copy number alterations.
DOI 10.1038/s41525-021-00259-9 - BiophysicsbioRxivPreprint
Anatomically Informed 3D Printed CT phantoms: The First Step of a Pipeline To Identify Robust Quantitative Radiomic Features
U. Mahmood, A. Apte, C. Kanan…·A. S. Dave
This paper demonstrates the feasibility of creating 3D printed CT phantoms from patient data to assess the repeatability and robustness of radiomic features across different scanning parameters.
DOI 10.1101/773879 - Cancer BiologybioRxiv
Robust and Interpretable PAM50 Reclassification Exhibits Survival Advantage for Myoepithelial and Immune Phenotypes
J. Mathews, S. Nadeem, A. J. Levine…·A. Tannenbaum
The paper reclassifies breast tumors into 7 classes using interpretable mRNA signatures, showing improved survival outcomes for myoepithelial and immune-related phenotypes.
DOI 10.1038/s41523-019-0124-8